Test Updates Memorandum – Mitochondrial

Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made.

The following panels will be updated by removing these genes:

ACACA, ACACB, ACADL, ATP5O, COX4I1, COX7A1, CPT1B, MRPL40, MRPS18A, MRPS2, MRPS22, MRRF, MTHFD1L, NDUFA7, NDUFB6, NDUFB8, NDUFS5, NDUFV3, SDHAF2, SIRT1, SIRT3, SIRT5, SUCLG2, TFAM, TFB1M, TMEM127, TOMM20, TOP1MT, UQCR10.

  • Dual Genome Panel (TC 2085)
  • Nuclear Panel (TC 2086)
  • Fatty Acid Oxidation Deficiency Panel (TC 2095)
  • Cobalamin Metabolism Panel + Severe MTHFR Deficiency (TC 2120)
  • MtDNA Depletion/Integrity Panel (TC 2130)
  • Mitochondrial Respiratory Chain Complex I Deficiency Panel (TC 2155)
  • Mitochondrial Respiratory Chain Complex II Deficiency Panel (TC 2160)
  • Mitochondrial Respiratory Chain Complex IV Deficiency Panel (TC 2170)
  • Mitochondrial Respiratory Chain Complex I-V Nuclear Gene Deficiency Panel (TC 2180)
  • Myopathy/Rhabdomyolysis Panel (TC 2300)
  • Dual Genome Leigh Disease Panel (TC 20600)
  • Leigh Disease Panel (TC 20601)
  • Hypoglycemia Panel (TC 21000)
Previous Post
Test Discontinuation Memorandum
Next Post
Test Discontinuations Memorandum – Mitochondrial

Menu